Recent HROW News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/18/2026 09:00:16 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/11/2026 08:31:32 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/11/2026 08:20:47 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/11/2026 08:10:43 PM
- Harrow Announces First Quarter 2026 Financial Results • GlobeNewswire Inc. • 05/11/2026 08:05:00 PM
- Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026 • GlobeNewswire Inc. • 04/27/2026 11:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/24/2026 08:07:30 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/24/2026 08:05:43 PM
- Harrow Announces the Issuance of J-Code for IOPIDINE® 1% • GlobeNewswire Inc. • 04/16/2026 11:00:00 AM
- LogiCare3PL Selected as Distribution Partner by Harrow • PR Newswire (US) • 04/14/2026 02:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 08:05:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 08:58:32 PM
- Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030 • GlobeNewswire Inc. • 03/24/2026 08:57:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/24/2026 12:16:17 PM
- Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support Growth • GlobeNewswire Inc. • 03/24/2026 12:15:00 PM
- Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual Meeting • GlobeNewswire Inc. • 03/18/2026 11:00:00 AM
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 03/11/2026 06:50:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/10/2026 12:26:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2026 09:05:14 PM
- Harrow to Present at Leerink Partner’s 2026 Global Healthcare Conference • GlobeNewswire Inc. • 03/04/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/03/2026 09:05:17 PM
- Harrow Wins FDA Clearance to Launch Phase 3 Trial Aimed at Expanding TRIESENCE Label in Cataract Surgery • IH Market News • 03/03/2026 03:39:49 PM
- Harrow to Initiate Phase 3 Clinical Trial Seeking to Expand TRIESENCE® Label to Include Ocular Inflammation and Pain Following Cataract Surgery Indication • GlobeNewswire Inc. • 03/03/2026 12:00:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 09:31:33 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/02/2026 09:15:59 PM
